This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Kevin Fitzgerald, PhD.
Chief Scientific Officer at Epsilogen
Speaker

Agenda Sessions

  • Chairperson's Remarks

    14:10
  • The Therapeutic Potential of IgE and IgE-derived Antibodies

    14:15